Search Results 141-150 of 16458 for Cefprozil

  1. Norgestrel (oral route) - Side effects & dosage - Mayo Clinic

    Cefprozil; Ceftazidime; Ceftibuten; Cefuroxime; Cenobamate; Clobazam; Clomipramine; Cloxacillin; Colesevelam; Cyclacillin; Cyclosporine; Dabrafenib; Darunavir ...

  2. Cardiovascular Medicine - Clinical trials

    The objective of this proposal is to assess blood-plasma volume (TBV-PV) status quantitatively in patients with DHF admitted to hospital for volume ...

  3. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...

  5. News - Gelareh Zadeh - Mayo Clinic

    2025. New genetic biomarker flags aggressive brain tumors Nov. 22, 2025, 03:00 p.m. CDT. 2024. Mayo Clinic names new Department of Neurosurgery chair in ...

  6. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  7. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  8. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...

  9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel - Mayo Clinic

    About this study. The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with ...